We previously reported that transgenic expression of this senescence-inhibitory p53 isoform counteracts aging-associated pathological changes in progeria model mice (heterozygous <i>Lmna<sup>G609G/+</sup></i> ). The gene discussed is TP53; the disease is progeroid syndrome.